Compare JetBlue Airways Corporation (JBLU) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JetBlue Airways Corporation vs Kymera Therapeutics Inc. Common Stock — how do they compare? JetBlue Airways Corporation trades at $3.05 (market cap $1.13B), while Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.88B). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 7.9× JetBlue Airways Corporation's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, JetBlue Airways Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold JetBlue Airways Corporation for 44 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| JBLU | KYMR | |
|---|---|---|
Market Cap | $1.13B | $8.88B |
Volume | 40,474,891 | 1,028,790 |
Sector | Industrials | Health |
52-Week High | $6.46 | $127.31 |
52-Week Low | $3.01 | $55.80 |
Typical Hold Time | 44 Days | 0 Days |
Enterprise Value | $8.50B | $8.27B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JetBlue (JBLU) trades at $3.35, down 7.46% today, reflecting persistent bearish sentiment amid negative earnings and high debt. The technical outlook is bearish with key support at $3, while fundamentals show revenue near $9.1B but net losses widening, with a negative ROE of -44.36%. Recent news includes route expansion in Colombia but also capacity cuts and elevated fuel costs pressuring margins.
The stock faces significant headwinds from consecutive quarterly losses and rising leverage, yet analyst consensus suggests a $5.89 price target implies potential upside if cost controls improve. Key risks include volatile fuel prices, competitive pressures, and execution of the JetForward strategy amidst a challenging macroeconomic backdrop for airlines.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →
